Not a good buy right now: price is extended near resistance with overbought momentum while short-term pattern stats lean bearish over the next week/month.
With earnings (QDEC 2025) on 2026-02-09 pre-market and no proprietary buy signals, the risk/reward for an immediate entry is unfavorable.
Better stance right now is HOLD / avoid chasing; consider only on a pullback toward support (around the pivot ~30.57) if you must enter quickly.
Technical Analysis
Trend: Bullish structure (SMA_5 > SMA_20 > SMA_200) suggests an established uptrend.
MACD: Histogram is negative (-0.0244) but contracting, implying downside momentum is fading—however it’s not a fresh upside momentum trigger yet.
Key levels: Pre-market ~31.23 is just below R1 (31.297); upside is capped short-term unless it cleanly breaks and holds above R1. Pivot support ~30.567, then S1 ~29.837.
Pattern-based forward bias: Similar-candlestick model shows ~40% chance of -0.16% next day, -3.6% next week, -4.57% next month (tilts against buying now).
Gross margin: 42.66 (down 6.94% YoY), a key watch item suggesting some margin compression despite strong earnings growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data was provided, so a Wall Street pro/con summary cannot be validated from the dataset.
Positioning signals: hedge funds neutral; insiders neutral; no recent congress trading data available (no influential-flow confirmation either way).
Wall Street analysts forecast IX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast IX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
